The criteria for stopping medication for hepatitis B minor triyang are the disappearance of hepatitis B surface antigen and undetectable HBV DNA. Hepatitis B minor triple positive means that hepatitis B surface antigen, hepatitis B e antibody and hepatitis B core antibody are positive, while hepatitis B surface antibody and hepatitis B e antigen are negative. For hepatitis B e antigen negative chronically infected people, after taking antiviral therapy such as entecavir and tenofovir disoproxil fumarate, the medication can be stopped if the hepatitis B surface antigen disappears and HBV DNA is undetectable. After stopping the antiviral drugs, there is a possibility of relapse, so after stopping the drugs, the two half pairs of tests, liver function and HBV DNA should be rechecked regularly. if there is a sign of reactivation, i.e., the surface antigen of hepatitis B or the e antigen of hepatitis B becomes positive, the glutamic oxaloacetic enzyme is elevated, and the HBV DNA turns to be positive again, the patient should be treated again. The treatment of hepatitis B teratitis minor should be carried out under the guidance of a doctor, taking medication regularly and not stopping the medication on its own, because stopping the medication on its own may lead to a severe acute exacerbation of hepatitis B and result in drug resistance, which will make the subsequent treatment more difficult.